has been cited by the following article(s):
[1]
|
Is there a reason for concern or is it just hype? – A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars
Expert Opinion on Biological Therapy,
2017
DOI:10.1080/14712598.2017.1341486
|
|
|
[2]
|
BIOSIMILAR ESAS: A COMPARATIVE REVIEW
Journal of Renal Care,
2015
DOI:10.1111/jorc.12099
|
|
|
[3]
|
BIOSIMILAR ESAS: A COMPARATIVE REVIEW
Journal of Renal Care,
2015
DOI:10.1111/jorc.12099
|
|
|
[4]
|
Biosimilars Are Here: A Hospital Pharmacist’s Guide to Educating Health Care Professionals on Biosimilars
Hospital Pharmacy,
2015
DOI:10.1310/hpj5010-884
|
|
|
[5]
|
Pharmacokinetic and pharmacodynamic considerations on the erythropoietin effect and adverse events of darbepoetin
Expert Opinion on Drug Metabolism & Toxicology,
2014
DOI:10.1517/17425255.2015.989832
|
|
|